Twist Bioscience Corporation
Every calculator, already run for TWST
Open the full toolkit →You have the numbers on TWST. Get the argument.
A written report on which of these readings actually decide the outcome for Twist Bioscience Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
13 analysts covering TWSTAnalyst Price Target Disagreement for Twist Bioscience Corporation
Wall Street's bull case implies -3% from the current price; the bear case implies -78%. A 75% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for TWST
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Twist Bioscience Corporation
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It provides NGS tools comprising library preparation kits, hu…
TWST — frequently asked
Is TWST a buy right now?
Wall Street's consensus rating on Twist Bioscience Corporation is Buy across 13 analysts, with a mean price target of $109.58 (-33% vs. the current $164.60). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is TWST's next earnings date?
Twist Bioscience Corporation is next scheduled to report earnings around Nov 16, 2026. A full TWST research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Twist Bioscience Corporation?
Analysts covering Twist Bioscience Corporation (TWST) range from a bear-case target of $36.00 to a bull-case high of $160.00, with a mean consensus target of $109.58 across 12 analysts. The spread of $124.00 (75% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Twist Bioscience Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Twist Bioscience Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full TWST research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Twist Bioscience Corporation, in minutes. 3 free reports included with every account — no credit card required.